Seres Therapeutics, Inc. | Business Operations | Business Contracts

Supply Agreement, dated September 15, 2015, by and between Seres Therapeutics, Inc. and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on November 2, 2022)

Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC (Filed With SEC on June 30, 2022)

Sales Agreement, dated as of May 21, 2021, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on May 21, 2021)

Advisory Agreement, dated December 12, 2019, by and between the Registrant and Roger Pomerantz (Filed With SEC on March 2, 2020)

Research Collaboration and Option Agreement, dated March 11, 2019, by and between the Registrant and MedImmune, LLC (Filed With SEC on May 2, 2019)

Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on March 18, 2020)

Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 27, 2019)

Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)

Seres Therapeutics, Inc. (90) | Business Operations (8)